New medical condition identified for men suffering with low testosterone Jun 21, 2016 Study finds 85 percent of men treated with testosterone therapy not suffering from classical primary or secondary hypogonadism, but adult onset hypogonadism.
Mouse model shows that Notch activation can drive metastatic prostate cancer Jun 13, 2016 Researchers find that in mouse models, Notch signaling promotes the ability of tumors to spread to other organs.
Differences in metabolism between androgen-dependent and castration resistant prostate cancer may lead to new therapies May 19, 2016 Researchers have determined that castration resistant prostate cancer has particular metabolic characteristics that may open new possibilities for treatment.
Study shows benefits of testosterone treatment in older men with low testosterone Feb 17, 2016 Baylor researchers part of study that shows improved sexual function, walking ability and mood after testosterone treatment in men age 65 and older.
Dan L Duncan Comprehensive Cancer Center joins nation’s cancer centers in endorsement of HPV vaccination for cancer prevention Jan 27, 2016 The Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine has joined the National Cancer Institute-designated cancer centers in issuing a statement urging for increased HPV vaccination to prevent cancer.
Electronic trigger reduces delays in evaluation for cancer diagnosis Aug 24, 2015 Electronic triggers designed to search for key data were able to identify and reduce follow-up delays for patients being evaluated for a diagnosis of colon or prostate cancer.
Baylor’s Dan L Duncan Cancer Center receives highest National Cancer Institute designation – Comprehensive status Jul 30, 2015 The National Cancer Institute has awarded the Dan L Duncan Cancer Center at Baylor College of Medicine the prestigious designation of a Comprehensive Cancer Center.
Baylor College of Medicine's Duncan Cancer Center receives additional $15.9 million in state cancer funding May 29, 2015 Researchers in the NCI-designated Dan L Duncan Cancer Center at Baylor College of Medicine have received $15.9 million from the Cancer Prevention and Research Institute of Texas for two new large grants focused on liver cancer and prostate cancer.
Baylor College of Medicine receives an additional $11 million in state cancer funding Feb 23, 2015 Baylor researchers receive nine new grants totaling $11.3 million in the latest round of funding awarded by the Cancer Prevention and Research Institute of Texas.
Coactivator forges pathway for prostate cancer metastatic survival Feb 16, 2015 New finding could help define pathway to develop a drug against prostate cancer metastasis, according to researchers at Baylor.
Erectile dysfunction may be first sign of heart disease Feb 16, 2015 Men with erectile dysfunction may also have an increased risk for developing heart disease, said an expert at Baylor College of Medicine in Houston.
More clinics moving to new building on McNair Campus Jan 14, 2015 The phased move-in of the Baylor College of Medicine Medical Center at the McNair Campus continues next week, when several clinics will open on the ninth floor.
Study looks at effect of diet on prostate cancer progression Jan 9, 2015 Recent studies suggest that nutrients found primarily in vegetables and fruits can help lower the risk of prostate cancer.
'Wound response' of cancer stem cells may explain chemo-resistance in bladder cancer Dec 3, 2014 A novel mechanism – similar to how normal tissue stem cells respond to wounding – might explain why bladder cancer stem cells actively contribute to chemo-resistance after multiple cycles of chemotherapy drug treatment.
Facial hair brings awareness to unique medical approaches, treatments at Baylor College of Medicine Nov 14, 2014 The Movember and No-Shave November movements have men’s health in their crosshairs, and Baylor College of Medicine is doing its part to raise awareness by providing individualized, tailored approaches to prostate cancer screening and erectile dysfunction.
SRC-2 drives castration-resistant prostate cancer Oct 9, 2014 Finding a blocker for the nuclear receptor coactivator known as NCoA2 or SRC-2 might solve the problem of treating advanced prostate cancer that becomes resistant to the most common treatment.
Study identifies new genetic cause of male reproductive birth defects Jun 1, 2014 Baylor team finds certain male reproductive birth defects resulted from a change in the number of copies of a gene, VAMP7.
High throughput “viewing” identifies new regulator of estrogen receptor Jan 23, 2014 A high throughput microscopy technique enabled our researchers to identify a a highly amplified gene in many tumors, including breast, prostate and ovarian cancer.
Metabolism, chromatin state gene implicated in common kidney cancer Jun 21, 2013 The Cancer Genome Atlas consortium has identified contributions to development of the most common form of adult kidney cancer.
Maintaining male sexual health can contribute to overall health Jun 18, 2013 Baylor College of Medicine expert encourages men to talk to their doctors about sexual health issues because these issues could contribute to other health problems.